Cresco Labs Inc (FRA:6CQ)
€ 0.65 (0%) Market Cap: 254.96 Mil Enterprise Value: 656.51 Mil PE Ratio: 0 PB Ratio: 0.81 GF Score: 63/100

Q2 2026 Cresco Labs Inc Earnings Call Transcript

Aug 6, 2026 / 12:30 PM GMT
Release Date Price: €0.582 (-0.51%)

Key Points

Positve
  • Cresco Labs Inc (CRLBF) delivered strong Q2 2026 results with revenue of $173 million, up 15% sequentially, and adjusted EBITDA of $40 million, up 20% sequentially, demonstrating solid operating leverage.
  • The company's strategic M&A in Pennsylvania is immediately accretive, with the nine acquired dispensaries already showing an 11% increase in gross profit dollars compared to pre-acquisition baselines.
  • Cresco Labs Inc (CRLBF) maintains leading market positions, holding the number one branded share in Pennsylvania (16%), Illinois, and Massachusetts, with Sunnyside stores generating over 30% more revenue than state averages.
  • The company is well-positioned for federal cannabis reform, with rescheduling expected to eliminate the 280E tax burden, improve net income, and open doors to U.S. exchange listings and cheaper capital.
  • Cresco Labs Inc (CRLBF) generated $15 million in operating cash flow in Q2, a significant improvement from a $6 million use in Q1, and continues to invest in growth areas like Kentucky and Ohio.
Negative
  • Cresco Labs Inc (CRLBF) faces intense competition in Illinois, where increasing vertical integration is shifting the retail landscape and pressuring the market.
  • The company expects Q3 2026 revenue to be roughly flat sequentially, as continued price compression and competition offset growth from new stores and the Kentucky launch.
  • Gross margins are expected to decline to the high 40% to 50% range in the second half of 2026 due to higher-cost inventory and temporary costs from facility upgrades.
  • The company experienced a setback in Texas, where its license application was awarded and then taken away, requiring legal action to recover the license.
  • Cresco Labs Inc (CRLBF) announced the departure of its CFO, Sharon Schuler, which introduces leadership transition risk during a critical period of growth and capital markets preparation.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CL.CD - Cresco Labs Inc
Q2 2026 Cresco Labs Inc Earnings Call
Aug 06, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and welcome to Cresco Labs second quarter 2026 earnings conference call.

All participants will be in listen-only mode.

Should you need assistance, please signal a conference specialist by pressing the star key followed by zero.

After today's presentation, there will be an opportunity to ask questions.

To ask a question, you may press the star key then 1 on your touch tone phone.

To withdraw your question, please press the star key then 1 again.

Please note this event is being recorded.

I would now like to turn the call over to TJ Cole, Senior Vice President, Corporate Development and Investor Relations for Cresto Labs. Please go ahead.

-------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot